Login to your account
The 7.2 mg dose of Wegovy is the highest strength available, and offers the potential for significant weight loss.
However, it is only available to some patients, and there are some important things to consider before increasing your dose from 2.4 mg. In this article, I outline key information about the 7.2 mg dose of Wegovy so you can see if it’s right for you.
Wegovy is a weight loss treatment that contains the active ingredient semaglutide, and 7.2 mg is the highest dose available. It works by suppressing your appetite and making you feel fuller after eating.
It is 3x stronger than the next dose down, and offers more effective results to those who have not achieved significant weight loss on the 2.4 mg dose.
For more information, you can read my article explaining Wegovy dosing.
The 7.2 mg dose of Wegovy is prescribed to people who haven’t seen significant weight loss on 2.4 mg. This offers another opportunity to reach your weight loss goals even if Wegovy hasn’t worked for you yet.
However, Wegovy 7.2 mg cannot be prescribed to everyone. To be prescribed the 7.2 mg dose, you must:
This ensures you can handle the lower dose before increasing it further and reduces the risk of side effects.
For most of my patients, the 2.4 mg dose of Wegovy is enough to achieve significant weight loss over time. Others may need a little extra to reach their goals. This is where the 7.2 mg dose comes in.
Here are some reasons you may not be seeing significant results on 2.4 mg Wegovy:
The 7.2 mg dose of Wegovy can offer significantly better weight loss results than the 2.4 mg dose.
Here’s what was found in a trial on Wegovy’s effectiveness:
There are no unique side effects of the 7.2 mg dose of Wegovy, but the risk of experiencing them is higher compared to the lower doses.
Here are the most common side effects of Wegovy, and the percentage of patients likely to experience them, according to the STEP UP trial:
| Side effect | Wegovy 7.2 mg (% of patients experiencing it) |
|---|---|
| Nausea | 38.9% |
| Diarrhoea | 24.2% |
| Vomiting | 22.1% |
| Dysaesthesia (unusual or unpleasant sensations) | 21.6% |
| Constipation | 20.4% |
| Hair loss | 5.3% |
These results are from patients who tolerated the 2.4 mg dose well. This shows an increased likelihood of developing side effects despite not experiencing any on lower doses.
Keep in mind, however, that side effects usually go away within weeks as your body gets used to the medicine.
For a full list of Wegovy side effects, see the patient information leaflet. For more information about side effects and how to manage them, you can also read our article about understanding Wegovy side effects.
As of 15 July 2026, the 7.2 mg Wegovy pen was approved in the EU for weight loss. This offers new possibilities for weight loss in patients who have not responded well to lower doses of Wegovy.
However, to buy it, you must have a prescription from a licensed healthcare provider like euroClinix.
At euroClinix, we offer Wegovy 7.2 mg at a competitive and comprehensive price. Your order will include:
For more information on how to start your consultation, visit our Wegovy page.
Answering your most common questions about GLP-1s
Reviewed by Dr. Allyson BettsBest exercises while taking GLP-1s for weight loss
Reviewed by Dr. Allyson BettsHow to keep the weight off after stopping Mounjaro
Reviewed by Dr. Elizabeth BhupalWhat to expect during your first month on Mounjaro
Reviewed by Dr. Allyson Betts
Why you may not be losing weight on Mounjaro
Reviewed by Dr. Allyson BettsMounjaro side effects explained
Reviewed by Dr. Allyson Betts
Select
medication
Fill out a short
medical form
Doctor issues
prescription
Medication sent
from pharmacy